Macular degeneration is one of the leading causes of vision loss, affecting millions worldwide, especially those over 60.
Macular degeneration is a leading cause of vision loss for people over 50, but there are ways to help protect your eyesight.
The unique challenges, and need for awareness, of age-related macular degeneration (AMD) is now formally recognized in Canada ...
Belite Bio is a biotech firm specializing in innovative therapies for retinal degenerative eye diseases with high unmet needs ...
Susvimo is also approved to treat age-related macular degeneration, and the medication, ranibizumab, is delivered though a ...
The new indication adds to the 2021 approval of Susvimo (ranibizumab) for 'wet' or neovascular age-related macular ...
The U.S. Food and Drug Administration (FDA) has approved ranibizumab injection (Susvimo, 100 mg/mL; Genentech) for the ...
In response to the TGA's approval of a new drug to treat macular degeneration, UNSW researcher Dr Lisa Nivison-Smith provides context about the ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback